Healthcare & Life Sciences
Industry knowledge and veteran experience in healthcare & life sciences
Strategic advice for public & private organisations
Our clients come to us because we have one of the most integrated and comprehensive life sciences practices in the CEE/SEE region, offering legal advice to the largest and most innovative life sciences companies.
In addition to our specialised expertise in different legal areas of the life sciences industry, our lawyers also understand the unique economic, regulatory, market and political climates facing you across the region.
You can rely on our firm’s deep bench of talent in virtually every discipline and our knowledge of local and regional government agencies. This means that whether you are a public or a private life science company, we can provide a full range of legal services at all stages of your development; from start-up and emerging growth companies to mature international and public companies.
Key experts
What others say about us
“The firm is recognised by clients for its work ethos, one saying: ‘I value the reliability in terms of keeping deadlines,’ and its ‘flexibility in offering customised solutions.'”
“Another client states: ‘They provide us with very good detailed legal advice and insights into […] healthcare law and adjacent areas.'”
– Chambers Europe
What makes our team the best law firm for you?
Our regional, integrated firm offers distinct advantages, spanning the full spectrum of legal services.
- An established international law firm with 60+ years of experience in Austria and CEE/SEE
- A fully integrated team of jurisdiction-specific qualified lawyers across our offices in 13 countries.
- Collaboration and innovation across multidisciplinary teams and offices
- Excellent client satisfaction – responsive, client-oriented, and consistent
- Experience with complex and cross-border matters covering the full spectrum of legal services
- Knowledge and expertise to add value to deals across industries
We can advise you in connection with:
- Advertising and Promotions
- Clinical Research Contracts
- Competition and Antitrust
- Compliance
- Consumer Actions and Tort Cases
- Cooperation Contracts with Life Sciences Professionals and Institutions
- Corporate / Mergers & Acquisitions
- Data Protection and Data Privacy
- Dispute Resolution
- Distribution and Agency Agreements
- Drug Admission & Labelling
- Employment Issues
- Foods and Food Additives
- Intellectual Property – Patents, Trademarks and Know-how
- Licensing
- Medical Products and Medical Devices
- Outsourcing
- Pharmaceuticals
- PPPs
- Pricing and Tariffs
- Product Liability
- Professional Liability
- Public Procurement Issues
- Regulatory Issues
- Reimbursement by Social Security Institutions
Get in touch
When you need an international team with extensive experience, Wolf Theiss is your right partner to support your business goals through profound legal practice.
Related insights
Hungarian legislation reform related to centralised procurement for institutional pharmacies
The governmental decree published on 22 February (No. 33/2024 (II. 22.)) sets forth the establishment of a new project com...
Read moreUkraine Takes Ground-breaking Step by Legalising Medical Cannabis to Enhance Patient Care
The President of Ukraine has officially signed Law No. 3528-IX “On Amendments to Certain Laws of Ukraine Regarding t...
Read moreLife Sciences Bulletin: Recent notable changes to life sciences regulation in Hungary
A reorganisation of the authorities regulating the pharma sector and new legislative pieces havebrought notable changes to...
Read moreLife Science Bulletin: Upcoming Changes to Parallel Distribution of Medicinal Products in Bulgaria
In August 2023, the Bulgarian Ministry of Health published a draft bill for amendment of the Law on Medicinal Products in ...
Read moreWolf Theiss advises Dr.Max Group on the acquisition of Gedeon Richter’s operations in Romania
Bucharest, 21 October 2022 – Dr.Max Group, owned by Penta Investments, relied on the legal expertise of Wolf Theiss for ...
Read moreWolf Theiss advises the shareholders of Dacia Plant on the sale of a majority stake to Ceres Pharma
Bucharest, 4 October 2022 – The shareholders of Dacia Plant relied on the legal advice of Wolf Theiss regarding the ...
Read moreEuropean Health Data Space: the future of health data access and sharing in the EU
By Ira Peric Ostojic and Sara Pavlovic The Covid-19 pandemic has highlighted the need to have timely access to and sharing...
Read more